The interleukin-2 receptor: a target for immunotherapy

Adv Exp Med Biol. 1992:323:57-66. doi: 10.1007/978-1-4615-3396-2_8.
No abstract available

Publication types

  • Review

MeSH terms

  • ADP Ribose Transferases*
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy*
  • Bacterial Toxins*
  • Exotoxins / administration & dosage
  • Exotoxins / therapeutic use
  • Gene Expression Regulation
  • Graft Rejection / prevention & control
  • Heart Transplantation
  • Humans
  • Immunotherapy / methods*
  • Immunotoxins / therapeutic use
  • Leukemia-Lymphoma, Adult T-Cell / immunology
  • Leukemia-Lymphoma, Adult T-Cell / therapy
  • Lymphocyte Activation
  • Macaca fascicularis
  • Mice
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Protein Engineering
  • Pseudomonas aeruginosa Exotoxin A
  • Receptors, Interleukin-2 / antagonists & inhibitors*
  • Receptors, Interleukin-2 / biosynthesis
  • Receptors, Interleukin-2 / chemistry
  • Receptors, Interleukin-2 / physiology
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / therapeutic use
  • Species Specificity
  • Virulence Factors*

Substances

  • Antibodies, Monoclonal
  • Bacterial Toxins
  • Exotoxins
  • Immunotoxins
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Virulence Factors
  • ADP Ribose Transferases